The research team has found that pro nerve growth factor is produced by prostate cancer cells and will now perform the pre-clinical studies needed to test pro nerve growth factor as a new biomarker for the diagnosis, prognosis and therapeutic target of prostate cancer.
Researchers
Dr Severine Roselli, Professor Hubert Hondermarck
Research Area
Project type
Project Grant
Year of funding
2014